Bettina Drake, PhD, MPH

Primary Academic Title

Professor of Surgery, Division of Public Health Sciences, Washington University School of Medicine

Research Interest

Identifying the modifiable and nonmodifiable risk factors for cancer as well as the at-risk groups for these factors; utilizing epidemiologic methods to understand the interactions between behavioral and biologic determinants of adverse cancer outcomes; and contributing to the translation of epidemiological findings into behavioral interventions at the individual and population level.

Education

2003: MPH, epidemiology, University of North Texas Health Science Center, Fort Worth
2006: PhD, epidemiology, University of South Carolina, Columbia

Training

2006 - 2009: Postdoctoral fellow, social epidemiology, Harvard University, Boston

Selected Research Publications

Where should the cancer control interventions target: A geospatial hotspot analysis for major cancer mortality 2018-2022 in the U.S.

Luo C, Khan S, Jin L, [...] Drake BF
Cancer Epidemiol Biomarkers Prev 2024

Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality.

Venkataraman V, Martin-Giacalone BA, Drake BF, [...] George S
J Clin Oncol 2024

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Wang A, Shen J, Rodriguez AA, [...] Drake BF, [...] Haiman CA
Nat Genet 2023

Local Treatment and Treatment-Related Adverse Effects Among Patients With Advanced Prostate Cancer.

Khan S, Chang SH, Wang M, [...] Drake BF
JAMA Netw Open 2023

Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer.

Khan S, Chang SH, Seyerle AA, [...] Drake BF
Prostate 2023

Adapting a Research and Community Capacity-Building Program to Address Rural Cancer Burden and Facilitate Partnership Development Between Rural Community Stakeholders and an Urban Comprehensive Cancer Center.

Lewis-Thames MW, Leahy N, Kruse-Diehr AJ, [...] Drake BF
J Cancer Educ 2023

Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.

Chen F, Madduri RK, Rodriguez AA, [...] Drake BF, [...] Haiman CA
Eur Urol 2023

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.

Moses KA, Sprenkle PC, Bahler C, [...] Drake BF, [...] Freedman-Cass DA
J Natl Compr Canc Netw 2023

Definitive treatment and risk of death among men diagnosed with metastatic prostate cancer at the Veterans Health Administration.

Drake BF, Khan S, Wang M, [...] Chang SH
Ann Epidemiol 2023

Strategies to Achieve Breast Health Equity in the St. Louis Region and Beyond over 15+ Years.

Drake B, James A, Miller H, [...] Thompson VS
Cancers (Basel) 2022

View All Publications